CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands |
Total |
Common Stock |
Treasury Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
| Beginning balance (in shares) at Dec. 31, 2023 |
|
165,066,195
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 1,152,295
|
$ 165,067
|
$ (113,407)
|
$ 1,701,163
|
$ (19,710)
|
$ (580,818)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
18,615,190
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
1,742
|
|
|
1,742
|
|
|
| Shares issued related to founders advisory fees - related party (in shares) |
|
1,758,464
|
|
|
|
|
| Shares issued related to founders advisory fees - related party |
0
|
$ 1,758
|
|
(1,758)
|
|
|
| Shares repurchased (in shares) |
|
|
2,969,357
|
|
|
|
| Shares repurchased |
(14,278)
|
|
$ (14,278)
|
|
|
|
| Net loss |
(82,558)
|
|
|
|
|
(82,558)
|
| Other comprehensive income (loss) |
(5,543)
|
|
|
|
(5,543)
|
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
166,824,659
|
|
|
|
|
| Ending balance at Mar. 31, 2024 |
1,051,658
|
$ 166,825
|
$ (127,685)
|
1,701,147
|
(25,253)
|
(663,376)
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
|
21,584,547
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
165,066,195
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
1,152,295
|
$ 165,067
|
$ (113,407)
|
1,701,163
|
(19,710)
|
(580,818)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
18,615,190
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(150,075)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
166,843,819
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
1,000,183
|
$ 166,844
|
$ (127,827)
|
1,707,664
|
(15,605)
|
(730,893)
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
21,603,481
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
166,824,659
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
1,051,658
|
$ 166,825
|
$ (127,685)
|
1,701,147
|
(25,253)
|
(663,376)
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
|
21,584,547
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
2,994
|
|
|
2,994
|
|
|
| Shares repurchased (in shares) |
|
|
18,535
|
|
|
|
| Shares repurchased |
(139)
|
|
$ (139)
|
|
|
|
| Net loss |
21,650
|
|
|
|
|
21,650
|
| Other comprehensive income (loss) |
(989)
|
|
|
|
(989)
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
166,824,659
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
1,075,174
|
$ 166,825
|
$ (127,824)
|
1,704,141
|
(26,242)
|
(641,726)
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
21,603,082
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
3,312
|
|
|
3,312
|
|
|
| Shares repurchased (in shares) |
|
|
399
|
|
|
|
| Shares repurchased |
(3)
|
|
$ (3)
|
|
|
|
| Warrants exercised (in shares) |
|
19,160
|
|
|
|
|
| Warrants exercised |
230
|
$ 19
|
|
211
|
|
|
| Net loss |
(89,167)
|
|
|
|
|
(89,167)
|
| Other comprehensive income (loss) |
10,637
|
|
|
|
10,637
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
166,843,819
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
$ 1,000,183
|
$ 166,844
|
$ (127,827)
|
1,707,664
|
(15,605)
|
(730,893)
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
21,603,481
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
169,426,114
|
169,426,114
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 1,157,270
|
$ 17
|
$ (127,827)
|
1,911,035
|
(39,232)
|
(586,723)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
21,603,481
|
|
21,603,481
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
$ 2,671
|
|
|
2,671
|
|
|
| Shares issued related to founders advisory fees - related party (in shares) |
|
1,837,304
|
|
|
|
|
| Shares repurchased (in shares) |
|
|
888,454
|
|
|
|
| Shares repurchased |
(8,183)
|
|
$ (8,183)
|
|
|
|
| Shares issued upon exercise of options (in shares) |
|
4,100
|
|
|
|
|
| Shares issued upon exercise of options |
41
|
|
|
41
|
|
|
| Net loss |
56,686
|
|
|
|
|
56,686
|
| Other comprehensive income (loss) |
7,885
|
|
|
|
7,885
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
171,267,518
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
$ 1,216,370
|
$ 17
|
$ (136,010)
|
1,913,747
|
(31,347)
|
(530,037)
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
22,491,935
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
169,426,114
|
169,426,114
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 1,157,270
|
$ 17
|
$ (127,827)
|
1,911,035
|
(39,232)
|
(586,723)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
21,603,481
|
|
21,603,481
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Shares issued upon exercise of options (in shares) |
2,055,834
|
|
|
|
|
|
| Net loss |
$ (66,135)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
173,301,872
|
173,301,872
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 1,111,348
|
$ 17
|
$ (168,197)
|
1,941,940
|
(9,554)
|
(652,858)
|
| Ending balance (in shares) at Sep. 30, 2025 |
25,378,156
|
|
25,378,156
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
171,267,518
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
$ 1,216,370
|
$ 17
|
$ (136,010)
|
1,913,747
|
(31,347)
|
(530,037)
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
22,491,935
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
2,238
|
|
|
2,238
|
|
|
| Shares repurchased (in shares) |
|
|
2,886,221
|
|
|
|
| Shares repurchased |
(32,187)
|
|
$ (32,187)
|
|
|
|
| Shares issued upon exercise of options (in shares) |
|
25,067
|
|
|
|
|
| Shares issued upon exercise of options |
251
|
|
|
251
|
|
|
| Net loss |
(32,161)
|
|
|
|
|
(32,161)
|
| Other comprehensive income (loss) |
24,120
|
|
|
|
24,120
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
171,292,585
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
1,178,631
|
$ 17
|
$ (168,197)
|
1,916,236
|
(7,227)
|
(562,198)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
25,378,156
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation |
6,519
|
|
|
6,519
|
|
|
| Shares issued upon exercise of options (in shares) |
|
2,009,287
|
|
|
|
|
| Shares issued upon exercise of options |
19,185
|
|
|
19,185
|
|
|
| Net loss |
(90,660)
|
|
|
|
|
(90,660)
|
| Other comprehensive income (loss) |
$ (2,327)
|
|
|
|
(2,327)
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
173,301,872
|
173,301,872
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 1,111,348
|
$ 17
|
$ (168,197)
|
$ 1,941,940
|
$ (9,554)
|
$ (652,858)
|
| Ending balance (in shares) at Sep. 30, 2025 |
25,378,156
|
|
25,378,156
|
|
|
|